secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEPHROS INC (NEPH)
CIK:        0001196298
Form:       8-K
Filed at:   2025-03-04T23:59:59+00:00
Accession:  0001493152-25-009035
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Nephros CFO Krandel gets two stock options, bonus target raised to 30%
----------------------------------------------------------------------

- Amendment to CFO Judith Krandel's letter agreement grants options for 54,359 and 58,961 shares under 2024 Equity Incentive Plan.
- First option vests 25% on first anniversary, then quarterly over 3 years; second vests upon closing a strategic transaction adding ≥$4M annual revenue.
- Annual performance bonus target increased to 30% of base salary; options accelerate upon termination without cause.
- Grant date is 3rd business day after filing 2024 10-K; exercise price equals closing price on grant date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1196298/000149315225009035/0001493152-25-009035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1196298/000149315225009035/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-009035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer